Tango Therapeutics (TNGX) Leases (2020 - 2025)
Historic Leases for Tango Therapeutics (TNGX) over the last 6 years, with Q3 2025 value amounting to $36.6 million.
- Tango Therapeutics' Leases fell 951.77% to $36.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.6 million, marking a year-over-year decrease of 951.77%. This contributed to the annual value of $39.5 million for FY2024, which is 926.73% down from last year.
- According to the latest figures from Q3 2025, Tango Therapeutics' Leases is $36.6 million, which was down 951.77% from $37.6 million recorded in Q2 2025.
- In the past 5 years, Tango Therapeutics' Leases ranged from a high of $47.8 million in Q3 2022 and a low of $520000.0 during Q2 2022
- For the 5-year period, Tango Therapeutics' Leases averaged around $33.0 million, with its median value being $40.4 million (2024).
- Its Leases has fluctuated over the past 5 years, first crashed by 8266.67% in 2021, then soared by 861634.62% in 2023.
- Tango Therapeutics' Leases (Quarter) stood at $1.3 million in 2021, then soared by 3507.69% to $46.9 million in 2022, then dropped by 7.23% to $43.5 million in 2023, then fell by 9.27% to $39.5 million in 2024, then decreased by 7.33% to $36.6 million in 2025.
- Its Leases stands at $36.6 million for Q3 2025, versus $37.6 million for Q2 2025 and $39.7 million for Q1 2025.